Trem compositions and uses thereof
AssigneeFlagship Pioneering Innovations VI, LLC
InventorsTheonie Anastassiadis, David Charles Donnell Butler, Neil Kubica, Qingyi Li
Life of this patent
Estimating the term…
Abstract
The invention relates generally to tRNA-based effector molecules having a non-naturally occurring modification and methods relating thereto.
Claims18
A method of delivering a tRNA-based effector molecule (TREM) to a cell or a subject, wherein the TREM comprises a non-naturally occurring modification at a nucleotide position corresponding to a selected nucleotide position of a reference sequence, wherein the reference sequence is SEQ ID NO:
- 622, and the selected nucleotide position is selected from nucleotide positions 2, 3, and 73 of SEQ ID NO:
- 622.
A method of delivering a tRNA-based effector molecule (TREM) to a cell or a subject, wherein the TREM has a sequence with 95% sequence identity to SEQ ID NO:
- 622 and comprises a non-naturally occurring modification at a nucleotide position selected from nucleotide positions 2, 3, 16, 52, and 73 of SEQ ID NO:
- 622.
Dependencies are inferred from the claim text.